Generated by AI
Insight Molecular Diagnostics Inc. is a molecular diagnostics company focused on precision testing for transplantation and oncology. The company develops and commercializes laboratory-developed, kitted research-use, and clinical diagnostic tests that help clinicians assess organ rejection, monitor therapeutic response, and characterize tumor biology. Its current portfolio includes GraftAssure, a blood-based platform for transplanted organ health monitoring, along with oncology assays such as DetermaIO and DetermaCNI. Insight Molecular Diagnostics also supports researchers, pharmaceutical customers, and healthcare systems with molecular diagnostic services and precision medicine solutions. Headquartered in Nashville, Tennessee, the company operates a clinical laboratory that serves U.S. medical and research markets.
Website2 International Plaza Dr.
Nashville, TN, 37217
United States
The latest articles about OCX.
Summary of Feb 10's posts. Generated by AI.
No summary yet.
Summary of Dec 15's posts. Generated by AI.
Summary of May 11's posts. Generated by AI.
Investors talking about OCX also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.